Prevalence, risk of death of type of coronary artery disease in heart attack patients

November 16, 2014

Duk-Woo Park, M.D., of the University of Ulsan College of Medicine, Seoul, Korea, and Manesh R. Patel, M.D., of the Duke Clinical Research Institute, Durham, N.C., and colleagues investigated the incidence, extent, and location of obstructive non-infarct-related artery (IRA) disease and compared 30-day mortality according to the presence of non-IRA disease in patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack). Obstructive non-IRA disease is blockage in arteries not believed to be the cause of a heart attack. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.

Acute STEMI is the leading cause of sudden cardiac death and typically arises from the blockage of a coronary artery. Because the presence of significant non-IRA disease in patients with STEMI has been found to be associated with recurrent angina, repeat revascularization, and worse prognosis, a comprehensive estimation of the extent and location of obstructive non-IRA disease may be clinically important information for physicians in the development of optimal treatment strategies, according to background information in the article.

The study included a sample of patients from eight international, randomized STEMI clinical trials published between 1993 and 2007. Among 68,765 patients enrolled in the trials, 28,282 patients with valid angiographic information were included in this analysis. Follow-up varied from 1 month to 1 year. To assess the generalizability of trial-based results, external validation was performed using observational data for patients with STEMI from the Korea Acute Myocardial Infarction Registry (KAMIR; n = 18,217) and the Duke Cardiovascular Databank (n = 1,812).

The researchers found that 53 percent of patients (n = 14,929) had non-IRA disease and there were no substantial differences in the extent and location of non-IRA disease according to the IRA territory (muscle or area served by the suspected heart attack artery with the blockage). The presence of non-IRA disease was significantly associated with increased 30-day mortality, compared to patients without non-IRA disease (3.3 percent vs 1.9 percent). The overall prevalence and association of non-IRA disease with 30-day mortality was consistent with findings from the KAMIR registry, but not with the Duke database.

"These findings require confirmation in prospectively designed studies, but raise questions about the appropriateness and timing of non­IRA revascularization in patients with STEMI," the authors write.
-end-
(doi:10.1001/jama.2014.15095; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: This study was supported in part by the John Bush Simson Fund. The statistical portion of the manuscript was funded by the Duke Clinical Research Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.

The JAMA Network Journals

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.